SSRIs and SNRIs are both antidepressants that work by keeping more of your brain’s chemical messengers available, but they differ in which messengers they target. SSRIs boost only serotonin, while SNRIs boost both serotonin and norepinephrine. That one extra chemical makes a real difference in what each class treats well, what side effects you can expect, and which one your provider might recommend for your situation.
How Each One Works in the Brain
Your brain cells communicate by releasing chemical messengers called neurotransmitters into the gaps between them. After a message is sent, the sending cell normally reabsorbs those chemicals through a process called reuptake. Both SSRIs and SNRIs block that reabsorption so more of the chemical stays active in the gap, strengthening the signal.
SSRIs (selective serotonin reuptake inhibitors) target only serotonin, a neurotransmitter involved in mood regulation, sleep, and appetite. Common SSRIs include fluoxetine (Prozac), sertraline (Zoloft), escitalopram (Lexapro), citalopram (Celexa), and paroxetine (Paxil).
SNRIs (serotonin-norepinephrine reuptake inhibitors) block reabsorption of both serotonin and norepinephrine. Norepinephrine plays a role in alertness, energy, and how your body processes pain signals. The most widely prescribed SNRIs are duloxetine (Cymbalta), venlafaxine (Effexor XR), desvenlafaxine (Pristiq), and levomilnacipran (Fetzima).
What Each Class Treats
Both SSRIs and SNRIs are used for depression, generalized anxiety disorder, and other mood conditions. For straightforward depression or anxiety, SSRIs are often the first choice because they’ve been around longer and tend to have a slightly milder side effect profile.
SNRIs have a broader reach because of the norepinephrine component. They’re frequently prescribed for chronic pain conditions like fibromyalgia and diabetic nerve pain, areas where SSRIs fall short. Your body has a built-in pain-dampening system that sends signals down from the brainstem to the spinal cord, dialing down pain before it reaches full awareness. Both serotonin and norepinephrine power that system. In conditions like fibromyalgia, those descending pain-control pathways appear to be weakened or absent. SNRIs help restore them by boosting both chemicals at the spinal level, which is why they reduce pain intensity in ways that SSRIs generally cannot. Studies on the SSRI paroxetine in fibromyalgia found some pain relief, but the effect was limited and consistently weaker than what duloxetine or milnacipran delivered.
If you’re dealing with depression alongside chronic pain or fatigue, the dual action of an SNRI can address both problems at once, which is a practical advantage over an SSRI.
Side Effects That Set Them Apart
Because both classes increase serotonin, they share a core set of side effects: nausea, headache, sleep changes, and digestive issues, especially in the first few weeks. Where they diverge comes down to that extra norepinephrine activity in SNRIs.
Sexual Side Effects
Sexual side effects are one of the most common reasons people want to switch antidepressants. SSRIs as a class carry the highest risk. Paroxetine has the worst reputation on this front, with fluoxetine, sertraline, citalopram, and escitalopram all in the high-risk category. Among SNRIs, venlafaxine also ranks high for sexual side effects. However, other SNRIs like desvenlafaxine, duloxetine, and levomilnacipran are grouped among the antidepressants least likely to cause these problems, according to Mayo Clinic. So “SSRI vs. SNRI” isn’t a clean divide here. The specific medication matters more than the class.
Blood Pressure and Heart Effects
This is a clearer dividing line. SSRIs have no meaningful effect on blood pressure. SNRIs, on the other hand, are associated with higher blood pressure and a greater incidence of hypertension. The reason is straightforward: blocking norepinephrine reuptake increases the activity of your sympathetic nervous system, the “fight or flight” system that controls heart rate and blood vessel constriction. That extra norepinephrine can sensitize the heart to sympathetic activation, increasing cardiac output and pushing blood pressure up. Research published by the American Heart Association concluded that SNRIs may be unsuitable for people with existing hypertension or vascular disease because of this tendency. If you already have high blood pressure, this is a factor worth discussing before starting an SNRI.
Other Norepinephrine-Related Effects
SNRIs are more likely to cause sweating, increased heart rate, and a jittery or activated feeling, especially at higher doses. Some people find this energizing in a helpful way. Others find it uncomfortable, particularly if anxiety is their primary issue. SSRIs tend to feel more calming by comparison, which is part of why they’re often preferred for anxiety disorders.
Stopping Either One: Discontinuation Syndrome
Both SSRIs and SNRIs can cause withdrawal-like symptoms if you stop them abruptly. This is called antidepressant discontinuation syndrome, and it typically begins within two to four days of your last dose. Symptoms include flu-like achiness, fatigue, headache, sweating, nausea, dizziness, vivid dreams, and electric shock-like sensations sometimes called “brain zaps.” Mood changes like irritability, anxiety, and agitation are also common.
Most cases are mild and resolve within eight weeks, but some can be severe and last a year or more. The underlying cause appears to be a sudden drop in serotonin levels after your brain has adapted to having more of it around. SNRIs with short half-lives (venlafaxine is the notable example) and SSRIs like paroxetine are considered the highest risk for difficult discontinuation. Gradually tapering the dose over weeks or months, rather than stopping cold, is the standard approach for either class.
Effectiveness for Depression
For major depression specifically, SSRIs and SNRIs perform similarly in clinical trials. There is no strong evidence that one class consistently outperforms the other in terms of how many people experience remission. What varies a lot is individual response. Someone who doesn’t improve on an SSRI may do well on an SNRI, and vice versa. The switch from one class to the other is one of the most common next steps when a first antidepressant doesn’t work.
The practical difference is less about raw effectiveness and more about matching the medication to your full picture. Depression with chronic pain or fatigue may respond better to an SNRI. Depression with prominent anxiety and no pain component may be a better fit for an SSRI, particularly if you have any cardiovascular concerns.
Quick Comparison
- Neurotransmitters: SSRIs target serotonin only; SNRIs target serotonin and norepinephrine
- Pain relief: SNRIs are effective for chronic pain conditions; SSRIs provide little to no pain benefit
- Blood pressure: SSRIs are neutral; SNRIs can raise blood pressure
- Sexual side effects: Highest with SSRIs as a class, though some individual SNRIs also carry high risk
- First-line for depression: SSRIs are typically tried first; SNRIs are a common second step or first choice when pain is involved
- Discontinuation risk: Both classes can cause withdrawal symptoms, with certain short-acting medications in each class being the worst offenders